SG10201500350PA - 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition - Google Patents
15-valent pneumococcal polysaccharide-protein conjugate vaccine compositionInfo
- Publication number
- SG10201500350PA SG10201500350PA SG10201500350PA SG10201500350PA SG10201500350PA SG 10201500350P A SG10201500350P A SG 10201500350PA SG 10201500350P A SG10201500350P A SG 10201500350PA SG 10201500350P A SG10201500350P A SG 10201500350PA SG 10201500350P A SG10201500350P A SG 10201500350PA
- Authority
- SG
- Singapore
- Prior art keywords
- vaccine composition
- protein conjugate
- conjugate vaccine
- pneumococcal polysaccharide
- valent pneumococcal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30272610P | 2010-02-09 | 2010-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201500350PA true SG10201500350PA (en) | 2015-03-30 |
Family
ID=44353903
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012058236A SG183199A1 (en) | 2010-02-09 | 2011-02-03 | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| SG10201500350PA SG10201500350PA (en) | 2010-02-09 | 2011-02-03 | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012058236A SG183199A1 (en) | 2010-02-09 | 2011-02-03 | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US8192746B2 (en) |
| EP (1) | EP2533805A4 (en) |
| JP (2) | JP2013518891A (en) |
| KR (1) | KR101538535B1 (en) |
| CN (1) | CN102858365A (en) |
| AR (2) | AR080122A1 (en) |
| AU (1) | AU2011216095B2 (en) |
| BR (1) | BR112012019757B8 (en) |
| CA (1) | CA2788680C (en) |
| CL (1) | CL2012002195A1 (en) |
| EC (1) | ECSP12012100A (en) |
| IL (1) | IL221283A0 (en) |
| MA (1) | MA34051B1 (en) |
| MX (1) | MX2012009206A (en) |
| MY (1) | MY159984A (en) |
| NZ (1) | NZ601711A (en) |
| PE (1) | PE20121698A1 (en) |
| RU (1) | RU2012138368A (en) |
| SG (2) | SG183199A1 (en) |
| TN (1) | TN2012000377A1 (en) |
| TW (1) | TW201136603A (en) |
| UA (1) | UA106115C2 (en) |
| WO (1) | WO2011100151A1 (en) |
| ZA (1) | ZA201205737B (en) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI445545B (en) | 2005-04-08 | 2014-07-21 | Wyeth Corp | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| KR20130122810A (en) | 2005-06-27 | 2013-11-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Process for manufacturing vaccines |
| NZ575272A (en) * | 2006-09-07 | 2012-02-24 | Glaxosmithkline Biolog Sa | Inactivated poliovirus type 1, diptheria toxoid, tetanus toxoid and killed whole-cell Bordetella pertussis vaccine |
| JP5917682B2 (en) | 2011-04-22 | 2016-05-18 | ワイス・エルエルシー | Composition and method for mutant Clostridium difficile toxin |
| WO2013078102A1 (en) * | 2011-11-23 | 2013-05-30 | Merck Sharp & Dohme Corp. | Method for preparation of aluminum hydroxyphosphate adjuvant |
| KR102057217B1 (en) * | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US20140193451A1 (en) * | 2012-10-17 | 2014-07-10 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| BR122016023101B1 (en) | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polypeptide, immunogenic composition comprising it, as well as recombinant cell derived from Clostridium difficile |
| KR20140075201A (en) * | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| KR20140075196A (en) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CN103495161B (en) * | 2013-10-08 | 2019-06-18 | 江苏康泰生物医学技术有限公司 | A kind of mixture and preparation method thereof of polynary pneumococcal capsular polysaccharide-protein conjugate |
| TWI586363B (en) * | 2013-10-30 | 2017-06-11 | Sk化學公司 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| KR102099741B1 (en) * | 2014-01-21 | 2020-04-10 | 화이자 인코포레이티드 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
| EP3096786B1 (en) | 2014-01-21 | 2021-07-07 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
| PE20161095A1 (en) * | 2014-01-21 | 2016-10-26 | Pfizer | IMMUNOGENIC COMPOSITIONS INCLUDING CONJUGATED CAPSULAR SACCHARID ANTIGENS AND THE USE OF THE SAME |
| EP3104886B1 (en) * | 2014-02-14 | 2018-10-17 | Pfizer Inc | Immunogenic glycoprotein conjugates |
| CN103893751B (en) * | 2014-03-26 | 2016-04-20 | 天津康希诺生物技术有限公司 | A kind of pneumococal polysaccharide Protein Conjugation vaccine and preparation method thereof |
| PE20180460A1 (en) * | 2015-06-08 | 2018-03-06 | Serum Inst Of India Private Ltd | METHODS TO IMPROVE THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND A MULTIVALENT VACCINE FORMULATION OBTAINED THROUGH THE SAME |
| PL3313436T3 (en) | 2015-06-23 | 2021-06-14 | Biological E Limited | Multivalent pneumococcal conjugate vaccine |
| RU2721128C2 (en) | 2015-07-21 | 2020-05-18 | Пфайзер Инк. | Immunogenic compositions containing conjugated antigens of the capsular saccharide, kits containing these compositions and use thereof |
| EP3347042A4 (en) | 2015-09-10 | 2019-02-20 | Inventprise, LLC. | Multivalent vlp conjugates |
| US11058757B2 (en) | 2016-03-31 | 2021-07-13 | Pogona, LLC | Saccharide-polypeptide conjugate compositions and methods of use thereof |
| EP3481407A4 (en) | 2016-07-08 | 2020-04-01 | Hawaii Biotech, Inc. | West nile virus vaccine and method of use thereof |
| AU2017306708B2 (en) | 2016-08-05 | 2021-08-26 | Sk Bioscience Co., Ltd. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| MX2019001342A (en) | 2016-08-05 | 2019-07-04 | Sanofi Pasteur Inc | Multivalent pneumococcal polysaccharide-protein conjugate composition. |
| EP3518965A1 (en) * | 2016-09-30 | 2019-08-07 | Biological E Limited | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| WO2018080213A1 (en) * | 2016-10-28 | 2018-05-03 | 주식회사 엘지화학 | Multivalent immunogenic composition having increased igg titer, and use thereof |
| JP7186166B2 (en) | 2016-12-30 | 2022-12-08 | バックスサイト・インコーポレイテッド | Polypeptide-antigen conjugates with unnatural amino acids |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| CN116870144A (en) | 2017-01-31 | 2023-10-13 | 默沙东有限责任公司 | Method for preparing polysaccharide-protein conjugates |
| KR102650073B1 (en) | 2017-01-31 | 2024-03-20 | 머크 샤프 앤드 돔 엘엘씨 | Method for producing capsular polysaccharide protein conjugate derived from Streptococcus pneumoniae serotype 19F |
| US11246918B2 (en) | 2017-02-03 | 2022-02-15 | Eva Barbara Schadeck | Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof |
| US20200054740A1 (en) * | 2017-02-24 | 2020-02-20 | Merck Sharp & Dohme Corp. | Pneumococcal conjugate vaccine formulations |
| KR20240011879A (en) | 2017-02-24 | 2024-01-26 | 머크 샤프 앤드 돔 엘엘씨 | Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates |
| WO2018156465A1 (en) * | 2017-02-24 | 2018-08-30 | Merck Sharp & Dohme Corp. | Polysaccharide-protein conjugates utilizing diphtheria toxin fragment b as a carrier |
| US11400162B2 (en) | 2017-02-24 | 2022-08-02 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| JP7132954B2 (en) * | 2017-06-10 | 2022-09-07 | インベントプライズ リミテッド ライアビリティ カンパニー | Multivalent conjugate vaccines comprising bivalent or multivalent conjugated polysaccharides providing improved immunogenicity and avidity |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| CN110996992A (en) * | 2017-08-16 | 2020-04-10 | 默沙东公司 | Pneumococcal conjugate vaccine formulations |
| EP3678654B1 (en) | 2017-09-07 | 2024-06-26 | Merck Sharp & Dohme LLC | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| AU2018328038B2 (en) * | 2017-09-07 | 2024-03-07 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| KR20200051003A (en) | 2017-09-07 | 2020-05-12 | 머크 샤프 앤드 돔 코포레이션 | Pneumococcal polysaccharide and its use in immunogenic polysaccharide-carrier protein conjugates |
| US11524076B2 (en) | 2017-09-07 | 2022-12-13 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| CN111093649B (en) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | Pneumococcal polysaccharide and its use in immunogenic polysaccharide-carrier protein conjugates |
| AU2018328040A1 (en) * | 2017-09-07 | 2020-03-19 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| KR20230130153A (en) * | 2017-12-06 | 2023-09-11 | 머크 샤프 앤드 돔 엘엘씨 | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| AU2019215216A1 (en) | 2018-02-05 | 2020-07-23 | Sk Bioscience Co., Ltd. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| MX2020007939A (en) | 2018-02-05 | 2020-09-03 | Sanofi Pasteur Inc | Multivalent pneumococcal polysaccharide-protein conjugate composition. |
| BR112020021296A2 (en) | 2018-04-18 | 2021-01-26 | Sk Bioscience Co., Ltd. | capsular polysaccharide of streptococcus pneumoniae and its immunogenic conjugate |
| EP3787673A4 (en) | 2018-04-30 | 2022-04-27 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates |
| US11896656B2 (en) | 2018-04-30 | 2024-02-13 | Merck Sharp & Dohme Llc | Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide |
| CN112074294A (en) * | 2018-04-30 | 2020-12-11 | 默沙东公司 | Method for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugate from freeze-dried spheres |
| WO2019220304A1 (en) * | 2018-05-14 | 2019-11-21 | Tergene Biotech Pvt. Ltd. | 15 valent pneumococcal polysaccharide conjugate vaccine |
| WO2020009462A1 (en) * | 2018-07-06 | 2020-01-09 | 주식회사 유바이오로직스 | Multivalent immunogenic composition comprising polysaccharide-protein conjugates, and vaccine comprising same for preventing disease caused by streptococcus pneumoniae |
| MX2021000548A (en) * | 2018-07-19 | 2021-07-02 | Glaxosmithkline Biologicals Sa | Processes for preparing dried polysaccharides. |
| CN112969474A (en) * | 2018-09-12 | 2021-06-15 | 艾芬尼维克斯公司 | Multivalent pneumococcal vaccine |
| US20220296695A1 (en) | 2018-12-19 | 2022-09-22 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| BR112021024491A8 (en) * | 2019-06-05 | 2023-04-11 | Merck Sharp & Dohme | IMMUNOGENIC COMPOSITION, AND METHOD FOR PREVENTING, TREATING, OR IMPROVING AN INFECTION, DISEASE, OR CONDITION |
| EP3980055A4 (en) * | 2019-06-05 | 2023-07-26 | Merck Sharp & Dohme LLC | An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same |
| KR20210010412A (en) * | 2019-07-18 | 2021-01-27 | (주)셀트리온 | The immunogenic composition comprising multivalent pneumococcal polysaccharide-protein conjugate |
| JP2022542316A (en) | 2019-07-31 | 2022-09-30 | サノフィ パスツール インコーポレイテッド | Polyvalent pneumococcal polysaccharide-protein conjugate compositions and methods of use thereof |
| KR20220102871A (en) * | 2021-01-14 | 2022-07-21 | (주)셀트리온 | The immunogenic composition comprising multivalent pneumococcal polysaccharide-protein conjugate |
| TW202245835A (en) | 2021-02-04 | 2022-12-01 | 美商默沙東有限責任公司 | Nanoemulsion adjuvant composition for pneumococcal conjugate vaccines |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| EA006313B1 (en) * | 2000-06-29 | 2005-10-27 | Глаксосмитклайн Байолоджикалс С.А. | Multi-valent immunogenic compositions and methods for using same |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| WO2005120563A2 (en) * | 2004-06-04 | 2005-12-22 | Pharmexa Inc. | Induction of an immune response against streptococcus pneumoniae polysaccharides |
| CN1660881A (en) * | 2005-01-12 | 2005-08-31 | 北京万赛生物医药技术发展有限公司 | New type molecules of immunization stimulus and preparation method |
| TWI445545B (en) * | 2005-04-08 | 2014-07-21 | Wyeth Corp | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| KR20130122810A (en) * | 2005-06-27 | 2013-11-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Process for manufacturing vaccines |
| US20090035326A1 (en) * | 2005-11-01 | 2009-02-05 | Novartis Ag | Compositions with antigens adsorbed to calcium phosphate |
| EP3470080A1 (en) * | 2005-12-22 | 2019-04-17 | GlaxoSmithKline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| AU2006327023A1 (en) * | 2005-12-23 | 2007-06-28 | Glaxosmithkline Biologicals Sa | Conjugate vaccines |
| US20070253985A1 (en) * | 2006-04-26 | 2007-11-01 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| PT2129693T (en) * | 2007-03-23 | 2017-02-14 | Wyeth Llc | Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides |
| CN101784282B (en) * | 2007-06-26 | 2015-07-08 | 葛兰素史密丝克莱恩生物有限公司 | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| CN101590224A (en) * | 2009-06-30 | 2009-12-02 | 广州精达医学科技有限公司 | High-efficiency 14-valent pneumococcal conjugate vaccine |
-
2011
- 2011-02-01 TW TW100104042A patent/TW201136603A/en unknown
- 2011-02-03 BR BR112012019757A patent/BR112012019757B8/en active IP Right Grant
- 2011-02-03 SG SG2012058236A patent/SG183199A1/en unknown
- 2011-02-03 CN CN2011800087423A patent/CN102858365A/en active Pending
- 2011-02-03 UA UAA201210582A patent/UA106115C2/en unknown
- 2011-02-03 US US13/020,402 patent/US8192746B2/en active Active
- 2011-02-03 AU AU2011216095A patent/AU2011216095B2/en active Active
- 2011-02-03 CA CA2788680A patent/CA2788680C/en active Active
- 2011-02-03 MX MX2012009206A patent/MX2012009206A/en active IP Right Grant
- 2011-02-03 WO PCT/US2011/023526 patent/WO2011100151A1/en active Application Filing
- 2011-02-03 US US13/577,810 patent/US20120301502A1/en not_active Abandoned
- 2011-02-03 PE PE2012001178A patent/PE20121698A1/en not_active Application Discontinuation
- 2011-02-03 MY MYPI2012003537A patent/MY159984A/en unknown
- 2011-02-03 NZ NZ601711A patent/NZ601711A/en unknown
- 2011-02-03 MA MA35187A patent/MA34051B1/en unknown
- 2011-02-03 AR ARP110100362A patent/AR080122A1/en unknown
- 2011-02-03 JP JP2012552069A patent/JP2013518891A/en not_active Ceased
- 2011-02-03 KR KR1020127020833A patent/KR101538535B1/en active IP Right Grant
- 2011-02-03 EP EP20110742633 patent/EP2533805A4/en not_active Withdrawn
- 2011-02-03 RU RU2012138368/15A patent/RU2012138368A/en not_active Application Discontinuation
- 2011-02-03 SG SG10201500350PA patent/SG10201500350PA/en unknown
-
2012
- 2012-07-24 TN TNP2012000377A patent/TN2012000377A1/en unknown
- 2012-07-30 ZA ZA2012/05737A patent/ZA201205737B/en unknown
- 2012-08-02 IL IL221283A patent/IL221283A0/en unknown
- 2012-08-07 CL CL2012002195A patent/CL2012002195A1/en unknown
- 2012-08-09 EC ECSP12012100 patent/ECSP12012100A/en unknown
-
2013
- 2013-09-13 JP JP2013189954A patent/JP2014012720A/en active Pending
-
2019
- 2019-08-30 AR ARP190102473A patent/AR116043A2/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL221283A0 (en) | 15-valent pneumococcal polysaccharide - protein conjugate vaccine composition | |
| EP2932979A4 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| PL2932980T3 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| EP2865392A4 (en) | Polyvalent pneumococcal polysaccharide-protein conjugate composition | |
| GB201003924D0 (en) | Immunogenic composition | |
| GB0913681D0 (en) | Immunogenic composition | |
| IL215389A0 (en) | Pneumococcal vaccine and uses thereof | |
| IL223206A0 (en) | Vaccine formulations | |
| GB201015132D0 (en) | Vaccine composition | |
| EP2529227A4 (en) | Cytomegalovirus-based immunogenic preparations | |
| ZA201209739B (en) | Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof | |
| EP2402032A4 (en) | Immunogenic composition | |
| IL242592A (en) | Immunogenic compositions | |
| PT2640417T (en) | Multivalent vaccine for filariasis | |
| HK1213594A1 (en) | Immunogenic compositions and uses thereof | |
| EP2525818A4 (en) | Immunogenic influenza composition | |
| EP2609931A4 (en) | Immunogenic composition | |
| IL214211A0 (en) | Stable vaccine compositions and methods for preparing the same | |
| EP2498815A4 (en) | Vaccine composition | |
| GB0913680D0 (en) | Immunogenic composition | |
| EP2252326A4 (en) | Vaccine compositions | |
| IL214127A0 (en) | Vaccine compositions | |
| EP2640418A4 (en) | Immunogenic compositions | |
| IL220308A0 (en) | Vaccine compositions | |
| GB0801122D0 (en) | Vaccine composition |